Nurse Anesthetist - CR in Riverton, WY Accepting Medicare
3 Nurse Anesthetist - CR nurses found. Showing 1 - 3
 Matthew Mullinix, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 2100 W Sunset Dr, Riverton, WY 82501 Phone: 800-967-1646 Fax: 317-567-2191 |
 Kari Sack, CRNA Nurse Anesthetist, Certified Registered Medicare: May Accept Medicare Assignments Practice Location: 2100 W Sunset Dr, Riverton, WY 82501 Phone: 800-967-1646 |
Ryan J Wilcox, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 2100 W Sunset Dr, Riverton, WY 82501 Phone: 800-967-1646 |
News Archive
Global leaders pledge to share COVID-19 vaccine doses internationally at the G7 summit
In a landmark agreement at the G7 summit, held in Cornwall, the United Kingdom of Great Britain and Northern Ireland, global leaders have pledged to share COVID-19 vaccine doses internationally, in support of global equitable access and to help end the acute phase of the pandemic.
State roundup: Mass. health law success; Penn. Medicaid cut reversed
Massachusetts has the nation's highest rate of residents with health insurance. Visits to emergency rooms are beginning to ease. More residents are getting cancer screenings and more women are making prenatal doctors' visits. Still, one of the biggest challenges for the state lies ahead: reining in spiraling costs.
Welch Allyn, LKC Technologies sign distribution agreement for RETeval DR screening device
Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, and LKC Technologies, Inc., the worldwide leader in visual electrophysiology and inventor of the RETeval DR diabetic retinopathy assessment device announced an exclusive distribution agreement.
Tetraphase Pharmaceuticals presents TP-434 drug candidate clinical data
Tetraphase Pharmaceuticals, Inc., yesterday presented new clinical and preclinical data for its lead drug candidate, TP-434, which demonstrated the novel antibiotic as a once daily intravenous (I.V.) monotherapy capable of treating multidrug-resistant gram-negative pathogens while also having potency and broad spectrum coverage of other serious and multidrug resistant gram-positive pathogens.
Strategies to minimize side effects of oxaliplatin in metastatic colon cancer
The drug oxaliplatin is a major reason the prognosis for metastatic colon cancer has gone from an expected survival of several months to a couple years. Unfortunately, the drug can also carry with it debilitating neurological side effects, which generally start as the sensation of pins and needles in fingers and toes and can leave patients unable to walk or dress independently.
› Verified 2 days ago
Registered Nurse
Nurse Practitioner
Nurse Anesthetist - CR
Physician Assistant
Clinical Nurse Specialist